STOCK TITAN

Bessemer funds eye more HNGE stock sales after recent disposals

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Bessemer Venture Partners entities filed a notice to sell 242,100 Class A shares through Merrill Lynch on the NYSE, with an aggregate market value of 9,383,796 and 37,919,155 Class A shares outstanding. The approximate sale date is 02/12/2026.

The shares to be sold were acquired on 02/04/2020 in a private placement from the issuer for cash. The filing also lists recent Class A share sales over the past three months by Bessemer Venture Partners X LP and Bessemer Venture Partners X Institutional LP, including multiple transactions in November and December 2025 with disclosed gross proceeds.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144 filing for HNGE disclose?

The filing discloses a planned sale of 242,100 Class A shares through Merrill Lynch on the NYSE. It also details how the shares were originally acquired and lists recent Class A share sales over the prior three months by related Bessemer Venture Partners entities.

How many HNGE Class A shares are proposed for sale?

The notice covers a proposed sale of 242,100 Class A shares. It reports an aggregate market value of 9,383,796 for this block, with 37,919,155 Class A shares outstanding, giving investors context on the relative size of the potential sale versus total shares.

When and how were the HNGE shares being sold acquired?

The 242,100 Class A shares were acquired on 02/04/2020 in a private placement from the issuer. The filing specifies that the purchase price was paid in cash on the same date, clarifying both the acquisition method and timing for these securities.

On which exchange are the HNGE Class A shares expected to be sold?

The filing indicates that the Class A shares are expected to be sold on the NYSE. Merrill Lynch, located at One Bryant Park in New York, is listed as the broker handling the transaction, and the approximate sale date disclosed is 02/12/2026.

What recent HNGE share sales by Bessemer funds are reported?

The document lists several Class A share sales in the past three months by Bessemer Venture Partners X LP and Bessemer Venture Partners X Institutional LP, including trades on 11/18/2025, 11/26/2025, 11/28/2025, and 12/05/2025, each with specified share amounts and gross proceeds.

What representation does the seller make about information on the issuer?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. The notice also warns that intentional misstatements or omissions of facts constitute federal criminal violations under 18 U.S.C. 1001.
Hinge Health, Inc.

NYSE:HNGE

HNGE Rankings

HNGE Latest News

HNGE Latest SEC Filings

HNGE Stock Data

3.11B
34.52M
8.08%
132.02%
1.61%
Health Information Services
Services-computer Processing & Data Preparation
Link
United States
SAN FRANCISCO